FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/01/079314 [Registered on: 23/01/2025] Trial Registered Prospectively
Last Modified On: 22/01/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To study the efficacy of Lodhradi Churna with Balchaturbhadra Churna in the management of Pittaj Atisara in children of age group 1 to 5 years  
Scientific Title of Study   Comparative Clinical Study to evaluate the efficacy of Lodhradi Churna with Balchaturbhadra Churna in the management of Pittaj Atisara in children of age group 1 to 5 Years. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Vivek Gitaram Chothe 
Designation  MD Scholar Kaumarbhritya  
Affiliation  MAM S Sumatibhai Shah Ayurved Mahavidyalaya Malwadi Hadapsar Pune 411028 
Address  MAM S Sumatibhai Shah Ayurved Mahavidyalaya Malwadi Hadapsar Pune OPD no 13 Department of Kaumarbhritya Sane Guruji Arogya Kendra Malwadi Hadapsar Pune
MAM S Sumatibhai Shah Ayurved Mahavidyalaya Malwadi Hadapsar pune OPD no 13 Sane Guruji Arogya Kendra Malwadi Hadapsar Pune 411028
Pune
MAHARASHTRA
411028
India 
Phone  8380833458  
Fax    
Email  vivekgchothe@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ramchandra Babar 
Designation  Professor of Department of Kaumarbhritya  
Affiliation  MAM S Sumatibhai Shah Ayurved Mahavidyalaya Sane Guruji Arogya Kendra  
Address  MAM S Sumatibhai Shah Ayurved Mahavidyalaya Malwadi Hadapsar OPD no 13 Department of Kaumarbhritya Sane Guruji Arogya Kendra Malwadi Hadapsar Pune

Pune
MAHARASHTRA
411028
India 
Phone  8275459236  
Fax    
Email  ramchandrababar@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Vivek Gitaram Chothe 
Designation  MD Scholar Kaumarbhritya 
Affiliation  MAM S Sumatibhai Shah Ayurved Mahavidyalaya Sane Guruji Arogya Kendra Malwadi Hadapsar Pune 
Address  MAM S Sumatibhai Shah Ayurved Mahavidyalaya Malwadi Hadapsar Pune OPD no 13 Sane Guruji Arogya Kendra Malwadi Hadapsar Pune

Pune
MAHARASHTRA
411028
India 
Phone  8380833458  
Fax    
Email  vivekgchothe@gmail.com  
 
Source of Monetary or Material Support  
Department Of Kaumarbhritya, Sane Guruji Arogya Kendra, Malwadi, Hadapsar Pune Maharashtra India 411028 
 
Primary Sponsor  
Name  Sane Guruji Arogya Kendra 
Address  Sane Guruji Arogya Kendra Malwadi Hadapsar Pune Maharashtra India 411028 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Vivek Gitaram Chothe  Sane Guruji Arogya Kendra  OPD no 13 Department Of Kaumarbhritya Sane Guruji Arogya Kendra Malwadi Hadapsar Pune
Pune
MAHARASHTRA 
8380833458

vivekgchothe@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC, MAMs Sumatibhai Shah Ayurved Mahavidyalaya and Sane Guruji Arogya Kendra   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:K929||Disease of digestive system, unspecified. Ayurveda Condition: ATISARAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Balchaturbhadra Churna, Reference: Bhaishajya ratnavali, Route: Oral, Dosage Form: Churna/ Powder, Dose: 1(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 7 Days, anupAna/sahapAna: Yes(details: Madhu), Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Lodhradi Churna, Reference: Yogratnakar Balchikitsa, Route: Oral, Dosage Form: Churna/ Powder, Dose: 1(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 7 Days, anupAna/sahapAna: Yes(details: Madhu), Additional Information: -
 
Inclusion Criteria  
Age From  1.00 Year(s)
Age To  5.00 Year(s)
Gender  Both 
Details  The study will select patients of age group 1 to 5 years, regardless of gender, socioeconomic status, or food habits. Eligible patients will exhibit at least classical symptoms of Pittaj Atisara, including Harit, Pita, Asita Malpravrutti, Trushna, Dahaa, Murchha, Udarsool, Jwara, Durgandhit Mala, and Sweda.
Additionally, patients with more than three episodes of loose motions in 24 hours, acute diarrhea with mild dehydration, and whose parents or guardians provide written consent and assent for participation in the clinical trial will be included. 
 
ExclusionCriteria 
Details  Patients having any chronic or systemic illness.
Patients of moderate to severe dehydration.
Patients suffering from Pravahika, Visuchika and Rakta atisara.
Patients suffering from chronic diarrhoea, persistent diarrhoea or diarrhoea due to congenital or acquired immunodeficiency.
Patients having major problems which require surgical corrections like intussusception and any other.
Patients with malabsorption syndrome.
Patients having diarrhoea due to lactose intolerence. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To evaluate efficacy of lodhradi churna and balchaturbhadra Churna in the management of pittaj atisara in children of age group 1 to 5 years.  Treatment will be given for 7 days.
Lodhradi churna will be given for one group and balchaturbhadra Churna will be given for another group.
Follow up and assessment will be done on 3rd, 5th and 7th day.
Final observation will be recorded after completion of treatment. 
 
Secondary Outcome  
Outcome  TimePoints 
Literature study of pittaj atisara in paediatric age
group.
To observe adverse effect if any. 
Study will be done using Ayurvedic Granthas & modern texts.
Preparation of drug will be done according to the standard procedure.
During the treatment observation will be done on 3rd, 5th & 7th day & later adverse effect. 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   05/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This comparative clinical study aims to assess the efficacy of Lodhradi Churna with Balchaturbhadra Churna in managing Pittaj Atisara in children of age group 1 to five years.
The study will consists of two trial groups, each with 40 patients, who will receive either Lodhradi Churna or Balchaturbhadra Churna along with Madhu for 7 days according to predefined assessment criteria.
Simple random sampling will be used to assign patients to each group and dosing will be determined based on patients age according to Dilling formula.

 
Close